Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-fluorodeoxyglucose-PET
- PMID: 8176475
Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-fluorodeoxyglucose-PET
Abstract
The purpose of this study was to determine the feasibility of FDG-PET imaging in women with silicone implant augmentation mammoplasties where mammographic detection of breast cancers is challenging due to the implants' radiodensity, which can obscure tumor visualization.
Methods: FDG-PET imaging was performed in two women with augmentation mammoplasties and small palpable breast abnormalities. Mammograms with and without breast displacement were also performed.
Results: PET clearly demonstrated focal FDG accumulation in the suspicious breasts, corresponding to tumors of less than 1.5 cm in diameter. There was no degradation of image quality by the implants and no need for breast displacement views. By contrast, implant displacement mammograms were necessary to fully delineate the tumors.
Conclusion: While mammograms with displacement views represent the initial choice for imaging the augmented breast, FDG-PET can image tumors in the augmented breast without implant displacement and without obvious degradation of image quality by the implant. FDG-PET warrants additional evaluation as an adjunctive study in the augmented breast, particularly when displacement mammographic views are not adequate or are impossible to perform due to peri-implant capsule formation.
Similar articles
-
A false-positive fluorodeoxyglucose positron emission tomography (FDG-PET) imaging result for a patient after augmentation mammaplasty.Aesthetic Plast Surg. 2009 Jul;33(4):611-5. doi: 10.1007/s00266-009-9347-7. Epub 2009 May 7. Aesthetic Plast Surg. 2009. PMID: 19421809
-
Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses.Eur J Cancer. 1992;28(2-3):635-40. doi: 10.1016/s0959-8049(05)80115-7. Eur J Cancer. 1992. PMID: 1591087
-
Improved mammographic imaging using tissue expanders for breast augmentation.Ann Plast Surg. 1994 Aug;33(2):119-27. doi: 10.1097/00000637-199408000-00001. Ann Plast Surg. 1994. PMID: 7979041 Clinical Trial.
-
Use of positron emission tomography in oncology.Oncology (Williston Park). 1993 Jul;7(7):41-6, 49-50; discussion 50-2, 55. Oncology (Williston Park). 1993. PMID: 8347460 Review.
-
The augmented breast.Radiol Technol. 2009 Jan-Feb;80(3):241M-259M. Radiol Technol. 2009. PMID: 19153201 Review.
Cited by
-
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?Eur J Nucl Med. 1997 Jun;24(6):691-705. doi: 10.1007/BF00841411. Eur J Nucl Med. 1997. PMID: 9169580 Review.
-
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.World J Surg. 2003 Oct;27(10):1099-104. doi: 10.1007/s00268-003-6893-z. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917770
-
Nuclear medicine techniques for the study of breast cancer.Eur J Nucl Med. 1997 Jul;24(7):809-24. doi: 10.1007/BF00879672. Eur J Nucl Med. 1997. PMID: 9211769 Review. No abstract available.
-
A false positive F-FDG PET/CT scan caused by breast silicone injection.Korean J Radiol. 2009 Mar-Apr;10(2):194-6. doi: 10.3348/kjr.2009.10.2.194. Epub 2009 Mar 3. Korean J Radiol. 2009. PMID: 19270867 Free PMC article.
-
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.Eur J Nucl Med. 1996 Dec;23(12):1641-74. doi: 10.1007/BF01249629. Eur J Nucl Med. 1996. PMID: 8929320 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical